• 出版社/出版日：Mordor Intelligence / 2021年7月26日
|Single User||￥484,500 (USD4,250)||▷ お問い合わせ|
|Team User||￥541,500 (USD4,750)||▷ お問い合わせ|
|Corporate License||￥855,000 (USD7,500)||▷ お問い合わせ|
・競争状況（Avanos Medical, Inc.、Cardinal Health、Fresenius Kabi AG、B. Braun Melsungen AG、ENvizion Medical Inc.、Applied Medical Technology, Inc.、Vygon、 Beckton, Dickinson and Company、Boston Scientific Corporation、CONMED Corporation、Cook Medical）
The enteral feeding tubes market is projected to register a CAGR of more than 6 % over the forecast period.
The ongoing COVID-19 pandemic has significantly impacted the enteral feeding tubes market growth globally. The intensive care units (ICUs) in hospitals across the globe have been witnessing a surge in admissions due to the SARS-CoV-2 induced respiratory failure leading to COVID-19 disease. As per a 2020 published report by the American Society for Parenteral and Enteral Nutrition (ASPEN), hospital staff across all the hospitals worldwide have been recommended to initiate enteral nutrition to the patients within 24-36 hours of intubation and placement. Thus, the COVID-19 pandemic has increased the need for enteral feeding tubes in hospitals.
The studied market growth can be largely attributed to the factors such as increasing incidences of chronic disorders, growing prevalence of malnutrition worldwide and rise in number of preterm births. These factors are fueling the demand for enteral feeding tubes.
With increasing incidences of chronic disorders, there is an increased demand for enteral feeding tubes. The nutritional management of patients suffering with disorders such as Parkinson’s disease, Alzheimer’s disease and motor neuron disease is crucial. In such patients, enteral feeding is a commonly used intervention to provide nutritional support and combat lack of appetite, dysphagia, and physical difficulty in consuming food. As per the Alzheimer’s Association report, in 2021, the number of Americans aged 65 years or above, suffering with Alzheimer’s dementia is 6.2 million and the number is projected to triple to 12.7 million by 2050. Thus, the increase in incidences of neurological disorders is expected to fuel the need for enteral feeding, thereby fueling the demand for enteral feeding tubes. Moreover, enteral nutrition is a low-risk and non-invasive therapy and is indicated for patients having a functional gastrointestinal tract as a first line induction therapy. As per a 2020 report by the International Foundation for Gastrointestinal Disorders (IFFGD), 10 to 15 % of the population is affected by irritable bowel syndrome worldwide, including 25 to 45 million people afflicted with the disease in the United States. Thus, with increase in incidence of metabolic and gastroenterology disorders, the adoption of enteral feeding will increase which will boost the demand for enteral feeding tubes.
Additionally, growing prevalence of malnutrition is augmenting the demand for enteral feeding tubes. As per the statistics by the World Health Organization (WHO) in 2020, worldwide, 149 million children under the age of 5 years were estimated to be stunted (too short for age), 45 million children were estimated to be wasted (too thin for height), and 38.9 million were overweight or obese. Thus, provision of nutritional supplements to such patients reduces complications such as wound breakage by 30% and death by 40%. This indicates the significantly increasing adoption of enteral feeding, thereby fueling the demand for enteral feeding tubes. Moreover, malnutrition is often not recognized in hospitalized patients, and patients can often remain malnourished throughout their hospital stay, thereby increasing their morbidity. Therefore, supplemental enteral nutrition is recommended to such patients via enteral feeding tubes.
Also, rise in number of preterm births is anticipated to increase the demand for enteral feeding tubes. Preterm infants have higher nutrient requirements than term infants and enteral feeding is the preferred route as they find difficulty in swallowing. According to the 2018 statistics by the World Health Organization (WHO), globally, an estimated 15 million babies are born preterm every year and approximately 1 million children die each year due to preterm birth complications. In addition, as per the 2020 statistics by the Centers for Disease Control and Prevention (CDC), in 2019, preterm birth 1 out of every 10 infants born in the United States. Such numbers indicate that the demand for enteral feeding tubes to provide adequate nutrition to such infants will increase with rise in number of preterm infants globally. Therefore, in view of the above-mentioned factors, the market is expected to witness a significant growth over the forecast period.
However,esophageal ulceration caused by enteral feeding tubes around the gastrostomy site and physical complications such as tube blockage, tube fracture, tube leakage and mispositioning of the tube are some of the factors impeding the market growth.
Key Market Trends
Oncology is Expected to Witness a Significant Over the Forecast Period
Based on application, the oncology segment is expected to witness significant growth over the forecast period. The major factors driving the growth of the market are the increasing number of cancer cases leading to rising demand for enteral feeding tubes and the need to provide adequate nutrition to cancer patients.
Patients suffering from head and neck squamous cell cancer (HNSCC) suffer from weight loss, anorexia, asthenia, and anemia. The location of tumors and the resulting damage to the oral/esophageal tissues from treatments make weight maintenance and obtaining proper nutrition extremely difficult. Therefore, nutritional support to such patients is provided through percutaneous endoscopic gastrostomy tubes. These tubes are also used in radiation or chemotherapy in cancer treatment, thereby allowing the patient to adapt to its use prior to treatments. As per the 2021 statistics by the World Health Organization (WHO), cancer accounted for nearly 10 million deaths in 2020. In addition, as per the 2021 statistics by the American Society of Clinical Oncology (ASCO), an estimated 66,630 people (48,740 men and 17,890 women) in the United States have been anticipated to develop head and neck cancer in 2021. Such numbers indicate that the increase in incidence of head and neck cancer will fuel the demand for enteral feeding tubes.
Additionally, gastric cancer remains the fifth most common malignancy in the world and the third leading cause of cancer death in males and females, worldwide. For instance, as per the 2021 statistics by the World Health Organization (WHO), approximately 1.09 million people were identified with stomach cancer globally. In stomach anorexia-cachexia syndrome is mainly caused by obstruction of upper digestive tract due to the mechanical effects of the tumor. Therefore, nutritional support via enteral feeding is recommended to such patients. This contributes to the rising demand for enteral feeding tubes. Thus, in view of the above-mentioned factors, the segment is expected to grow significantly over the forecast period.
North America is Anticipated to Observe a Significant Growth in the Global Enteral Feeding Tubes Market
North America is expected to majorly contribute to the market growth. Within North America, the United States has held the major share of the market. The major factors contributing to the growth of the market are the increasing incidences of chronic disorders in the region such as digestive disorders, diabetes, and cancer. For instance, as per the CDC (Centers for Disease Control), National Diabetes Statistics Report for 2020, cases of diabetes have risen to an estimated 34.2 million in 2020 from an estimated 1.8 million cases in 2018. Suboptimally managed diabetes increases the risk of stroke which will further increase the need for enteral feeding as these populations will face difficulty in swallowing, digestion, and assimilation. This factor indicates the growing demand for enteral feeding in healthcare facilities across the United States. Additionally, a high number of surgical procedures each year including liver transplants fuels the demand for providing enteral nutrition to patients in the United States. For instance, as per the 2020 statistics by the United States Department of Health and Human Services, approximately 39,034 liver transplants were performed in the United States in 2020. Moreover, the presence of large-scale manufacturers, high healthcare expenditure, and an increasing number of hospitalizations during the COVID-19 pandemic are some additional factors contributing to the increase in demand for enteral feeding tubes. Thus, in view of the aforementioned factors, market is expected to witness significant growth in North America over the forecast period.
The enteral feeding tubes market is nearly consolidated with a few major players dominating the market. The major players include B. Braun Melsungen AG, Boston Scientific Corporation, ENvizion Medical Inc., Cardinal Health, and Applied Medical Technology, Inc. The competition in the market is majorly based on technological advances. Additionally, the key players are involved in various strategic alliances, such as acquisitions, collaborations, and new product launches, to expand the global enteral feeding product portfolio and secure their positions in the global market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Chronic Disorders
4.2.2 Growing Prevalence of Malnutrition Worldwide
4.2.3 Rise in Number of Preterm Births
4.3 Market Restraints
4.3.1 Complications Associated with the Enteral Feeding Tubes
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value-USD million)
5.1 By Product Type
5.1.1 Nasoenteral Feeding Tube
5.1.2 Enterostomy Tube
5.1.3 Oroenteric Tube
5.2 By Patient Type
5.3 By Application Type
5.3.4 Metabolic Disorders
5.3.6 Other Applications
5.4 By End-user
5.4.2 Ambulatory Surgical Centers
5.5.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.5.4 Middle East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East and Africa
5.5.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Avanos Medical, Inc.
6.1.2 Cardinal Health
6.1.3 Fresenius Kabi AG
6.1.4 B. Braun Melsungen AG
6.1.5 ENvizion Medical Inc.
6.1.6 Applied Medical Technology, Inc.
6.1.8 Beckton, Dickinson and Company
6.1.9 Boston Scientific Corporation
6.1.10 CONMED Corporation
6.1.11 Cook Medical
*List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS